Item 2.02. Results of Operations and Financial Condition
On August 6, 2008, Savient Pharmaceuticals, Inc. (the “Registrant”) announced its financial results for the quarter and fiscal year ended June 30, 2008. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
In addition, on August 7, 2008, the Registrant held a publicly available live webcast discussion of its financial results for the quarter ended June 30, 2008. The transcript of the June 30, 2008 conference call is furnished as Exhibit 99.2 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits
| (d) |
Exhibits |
|
See Exhibit Index attached hereto. |
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| SAVIENT PHARMACEUTICALS, INC. | |||
| Date: August 7, 2008 | By: | /s/ Philip K. Yachmetz | |
| Philip K. Yachmetz | |||
| Executive Vice President & | |||
| Chief Business Officer | |||
EXHIBIT INDEX
| Exhibit No. | Description | |
| 99.1 | Press release dated August 6, 2008 | |
| 99.2 | Transcript dated August 7, 2008 |